154 related articles for article (PubMed ID: 27319282)
1. Hypoxia causes increased monocyte nitric oxide synthesis which is mediated by changes in dimethylarginine dimethylaminohydrolase 2 expression in animal and human models of normobaric hypoxia.
Lambden S; Martin D; Vanezis K; Lee B; Tomlinson J; Piper S; Boruc O; Mythen M; Leiper J
Nitric Oxide; 2016 Aug; 58():59-66. PubMed ID: 27319282
[TBL] [Abstract][Full Text] [Related]
2. Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis.
Lambden S; Kelly P; Ahmetaj-Shala B; Wang Z; Lee B; Nandi M; Torondel B; Delahaye M; Dowsett L; Piper S; Tomlinson J; Caplin B; Colman L; Boruc O; Slaviero A; Zhao L; Oliver E; Khadayate S; Singer M; Arrigoni F; Leiper J
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1382-92. PubMed ID: 25857313
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
Garbin U; Pasini AF; Stranieri C; Manfro S; Boccioletti V; Cominacini L
Pharmacol Res; 2007 Dec; 56(6):515-21. PubMed ID: 17977009
[TBL] [Abstract][Full Text] [Related]
4. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
Lambden S; Tomlinson J; Piper S; Gordon AC; Leiper J
Crit Care; 2018 Dec; 22(1):336. PubMed ID: 30538005
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
7. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls.
Brites-Anselmi G; Azevedo AMM; Miyazaki AHL; Pinheiro LC; Coeli-Lacchini FB; de Andrade MF; Molina CAF; Tucci S; Hirsch E; Tanus-Santos JE; Lacchini R
Nitric Oxide; 2019 Nov; 92():11-17. PubMed ID: 31394201
[TBL] [Abstract][Full Text] [Related]
8. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
Lu CW; Xiong Y; He P
Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
[TBL] [Abstract][Full Text] [Related]
9. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
[TBL] [Abstract][Full Text] [Related]
10. Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome.
Krishna MB; Joseph A; Thomas PL; Dsilva B; Pillai SM; Laloraya M
Cell Physiol Biochem; 2017; 43(5):1880-1892. PubMed ID: 29055959
[TBL] [Abstract][Full Text] [Related]
11. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
[TBL] [Abstract][Full Text] [Related]
13. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
[TBL] [Abstract][Full Text] [Related]
14. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene.
Zhang JG; Liu JX; Li ZH; Wang LZ; Jiang YD; Wang SR
Chin Med J (Engl); 2007 Dec; 120(23):2132-7. PubMed ID: 18167189
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
17. A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase.
Ragavan VN; Nair PC; Jarzebska N; Angom RS; Ruta L; Bianconi E; Grottelli S; Tararova ND; Ryazanskiy D; Lentz SR; Tommasi S; Martens-Lobenhoffer J; Suzuki-Yamamoto T; Kimoto M; Rubets E; Chau S; Chen Y; Hu X; Bernhardt N; Spieth PM; Weiss N; Bornstein SR; Mukhopadhyay D; Bode-Böger SM; Maas R; Wang Y; Macchiarulo A; Mangoni AA; Cellini B; Rodionov RN
Nat Commun; 2023 Jun; 14(1):3392. PubMed ID: 37296100
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
Lu CW; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Atherosclerosis; 2010 Mar; 209(1):66-73. PubMed ID: 19775692
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Desai A; Zhao Y; Warren JS
Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
